جست‌وجوی استاد و پژوهشگر

Swati Biswasمشاهده پروفایل

استاد

• Biostatistics
• Statistical Genetics
• Genetic Epidemiology
• +۳ مورد دیگر

Dr. Swati Biswas is a Professor and Associate Department Head in the Department of Mathematical Sciences at the University of Texas at Dallas (UTD). She holds a Ph.D. in Biostatistics from The Ohio State University (2003) and has held academic positions at UTD since 2012, including roles at the University of North Texas Health Science Center prior to that. Her research focuses on biostatistical methods for genetic epidemiology, cancer genetics, and risk prediction modeling, with a particular emphasis on Bayesian approaches. Education: B.Sc. (1994), M.Sc. (1996) in Statistics from the University of Delhi, followed by a Ph.D. in Biostatistics from The Ohio State University (2003). She completed a postdoctoral fellowship at MD Anderson Cancer Center (2004–2005). Research interests include statistical genetics, rare haplotype analysis, Bayesian clinical trials, and personalized risk prediction models for diseases like breast cancer and substance use disorders. She has developed tools such as CBCRisk for contralateral breast cancer prediction and Bayesian hierarchical models for pathway analysis. Her publications span over 40 peer-reviewed articles, focusing on methodological advancements in genetic association studies and clinical risk modeling. Notable awards include the 2016 Young Researcher Award from the International Indian Statistical Association and the 2011 President’s Award for Educational Excellence from UNT HSC. Dr. Biswas has secured grants totaling over $10M, including NIH funding for projects like multifrequency ultrasound imaging for breast cancer monitoring and Bayesian meta-analysis of cancer risk. She mentors doctoral students and has advised nine completed dissertations, with several current students.

Nicolas Prionasمشاهده پروفایل

پزشک-پژوهشگر

• Radiation Oncology
• Breast Cancer
• Quantitative Imaging
• +۳ مورد دیگر

Dr. Nicolas Prionas, MD PhD, is a radiation oncologist at the University of California San Francisco (UCSF) specializing in breast cancer detection, diagnosis, and management. A San Francisco Bay Area native, he focuses on expanding equitable access to radiation oncology through technological innovations including IMRT, SBRT, SRS, IGRT, and IORT. Stanford University B.S. 2005, Biomedical Computation Stanford University M.S. 2006, Biomechanical Engineering University of California, Davis PhD 2012, Biomedical Engineering University of California, Davis MD 2014, Medicine Stanford University Residency 2019, Radiation Oncology His research focuses on technologies enhancing equitable cancer care, particularly through novel breast CT imaging platforms and telemedicine applications. Recent work explores social media's role in treatment decision-making and motion monitoring systems for radiation therapy using smartphone technology. Key article trends include breast cancer management (2016-2024), stereotactic radiotherapy applications (2019-2021), telemedicine implementation (2020-2021), and prostate cancer outcomes analysis (2016-2021). 2019 Malcolm A. Bagshaw Award for leadership and scientific achievement 2018 NCCN Oncology Fellows Program Grant 2014 Transitional Intern of the Year at Santa Clara Valley Medical Center Multiple honors from University of California, Davis School of Medicine (2011-2014) As Director of Quality, he leads initiatives to improve radiation therapy protocols while maintaining active research collaborations across institutions. His work bridges clinical practice with technological innovation, particularly in breast cancer imaging and treatment optimization.

Aliah Hawariمشاهده پروفایل

پژوهشگر

• Cancer Genomics
• Computational Biology
• Metabolic Modeling
• +۳ مورد دیگر

Aliah Hawari is a Researcher in the Division of Cancer Sciences at the University of Manchester, affiliated with the Manchester Cancer Research Centre. She holds a PhD in Metabolic Modelling of Tomato Fruit Ripening from Oxford University (2010-2014), an MSc in Metabolic Modelling of Terpenoid Biosynthetic Pathways from Universiti Kebangsaan Malaysia (2007-2009), and a BSc in Bioinformatics (2003-2006). Her research focuses on computational biology, cancer genomics, and systems biology, with emphasis on early cancer detection in BRCA1/2 carriers through molecular profiling. Key areas include kinetic modeling, metabolic pathways, and ensemble modeling techniques. She actively supervises PhD students exploring topics like contralateral breast tissue analysis in genetic cancer predisposition. Recent work includes groundbreaking genomic analyses of colorectal cancers and advanced in silico models of biochemical pathways. Her contributions to defining informative priors for ensemble modeling have been widely adopted in systems biology research. Affiliated with the Manchester Cancer Research Centre and Healthier Futures initiative, her work aligns with global health goals in precision oncology and molecular diagnostics.

• Radiation Oncology
• Breast Cancer Treatment
• Radiotherapy Techniques
• +۵ مورد دیگر

Dr. Meena S. Moran is a Professor of Therapeutic Radiology at Yale School of Medicine and Chief of Breast Radiation Oncology at Yale New Haven Hospital. She specializes in breast cancer radiation therapy, focusing on improving treatment guidelines, healthcare delivery, and radiotherapy techniques. Her roles include Vice Chair of the NCCN Breast Panel and founding board member of the National Accreditation Program for Breast Centers (NAPBC). Education: MD from Cornell University Medical College (1994) Internal Medicine Residency at Roosevelt Hospital, Columbia University (1995) Radiation Oncology Residency at Yale-New Haven Hospital (1998) Research Interests: Breast cancer radiotherapy optimization, genomic risk stratification, partial breast irradiation, and quality assurance in healthcare. Her work emphasizes personalized care and improving patient outcomes through evidence-based protocols. Articles Trends: Her recent publications focus on optimizing radiation therapy protocols, evaluating outcomes of breast-conserving surgery, and addressing gaps in healthcare delivery. Key themes include hypofractionated radiotherapy, bolus use in postmastectomy care, and guideline adherence. Grants/Advising: Leads clinical trials such as the PREDICT-RT study for prostate cancer treatment. Collaborates with researchers on radiation dosimetry and clinical trial design. Mentors trainees in radiation oncology and translational research. Labs/Teams: Director of the Yale Medicine Breast Radiotherapy Program. Active in multidisciplinary teams at the Yale Cancer Center and the Breast Cancer Clinical Research Team.

Paul Cohenمشاهده پروفایل

استاد بالینی

• Gynaecological Cancers
• Ovarian Cancer
• Chemotherapy Resistance
• +۴ مورد دیگر

Paul Cohen is a Clinical Professor in the Division of Obstetrics and Gynaecology at the UWA Medical School, The University of Western Australia. He is also a Consultant at The Western Australian Gynaecological Cancer Service and a Clinical Research Fellow at the Harry Perkins Institute of Medical Research. His academic roles include editorial board memberships for International Journal of Gynecological Cancer and Scientific Reports . Education : Doctor of Medicine (MD), University of Auckland (2010), thesis: The Role of Oestrogen Receptor Beta in Ovarian Granulosa Cell Tumours BM BCh (Medicine), MA (Physiological Sciences), BA (Physiological Sciences), University of Oxford (1997–2001) Research Interests : Cohen’s work focuses on chemotherapy resistance in high-grade serous tubo-ovarian cancer, clinical trial design, and improving patient outcomes through innovations like the pathological chemotherapy response score (CRS). He leads national and international trials, including the Getting the MOST out of follow-up randomized controlled trial, and investigates genetic susceptibility (e.g., HELB gene in ovarian cancer). Recent Article Trends : His 2024–2025 publications emphasize genetic epidemiology, clinical trial implementation, and precision oncology, with contributions to understanding HPV-associated cancers and spatial transcriptomics in tumor microenvironments. Awards : 2024: UWA Medical School Excellence in Research (Mid-Career) 2022: UWA Excellence in Teaching Award 2021: Top Reviewer, International Journal of Gynecological Cancer Advising & Grants : Supervised 4 PhD, 3 MSc, and 3 MD students Principal Investigator for grants totaling over AUD 10M from MRFF, ANZGOG, and Cancer Research Trust Labs/Teams : Collaborates with ANZGOG, OTTA Consortium, and the Harry Perkins Institute of Medical Research. Leads the OVARIAN study and ADELE trial on endometrial cancer treatments.

Alexey Larionovمشاهده پروفایل

مدرس

• Bioinformatics
• Genomics
• Transcriptomics
• +۶ مورد دیگر

Dr. Alexey Larionov is a Lecturer in Bioinformatics at Cranfield University's Centre for Soil, Agrifood and Biosciences. With over 15 years of experience in applied bioinformatics, he specializes in analyzing various sequencing data types including genomics, transcriptomics, and metagenomics. Previously educated as a medical doctor in Russia (1992), he completed a PhD studying mechanisms and markers of endocrine resistance in breast cancer (1997) before transitioning to bioinformatics after earning an MSc in Applied Bioinformatics from Cranfield University (2012). His research interests span bioinformatics, genomics, transcriptomics, metagenomics, breast cancer research, endocrine resistance mechanisms, and cancer predisposition. Dr. Larionov has developed expertise in NGS data analysis, particularly focusing on heritable predisposition to cancer. His recent work has expanded into soil science applications, examining the soil microbial methylome and epigenetic memory in driving soil abiotic legacy effects. His publication trends show a progression from breast cancer research toward broader applications of bioinformatics in environmental science, with recent papers exploring soil ecosystems while maintaining his expertise in cancer genomics. His work demonstrates strong interdisciplinary connections between medical bioinformatics and environmental applications. Fellow of The Higher Education Academy (UK) Dr. Larionov supervises PhD students including Kavitha Vijeandran and John Pearce. He is a co-investigator on significant research grants including NERC's Restoring Resilient Ecosystems (NE/V006444/1) and BBSRC's Developing a resilient and regenerative tea production system (BB/Y003241/1). At Cranfield University, he teaches Python, epigenetics, proteomics, and metagenomics analysis in the Applied Bioinformatics MSc program, bridging computational methods with biological applications across multiple domains.

• Oncology
• Cancer Survivorship
• Testicular Cancer
• +۳ مورد دیگر

Ragnhild Hellesnes serves as an Associate Professor in the Department of Clinical Medicine at UiT The Arctic University of Norway, where her research focuses on cancer survivorship and treatment outcomes. She is actively engaged in translational oncology research with emphasis on long-term patient outcomes following cancer therapy. Her primary research interests center on testicular cancer survivorship, bladder cancer treatment efficacy, cisplatin-based chemotherapy effects, and late complications in cancer survivors. Hellesnes investigates critical areas including second cancer incidence, mortality patterns, psychosocial determinants of survival, and real-world treatment complications using population-based cohort methodologies. Analysis of her publication record reveals a consistent focus on national cohort studies examining long-term outcomes in testicular cancer patients treated in the cisplatin era. Her work demonstrates expertise in identifying modifiable prognostic factors, quantifying late relapse risks, and characterizing platinum-related toxicities through rigorous epidemiological approaches. Hellesnes is an active member of the Translational Cancer Research Group (TCRG) and contributes significantly to the "Testicular Cancer and Cancer Survivorship" project, which aims to improve understanding of long-term survivorship challenges and develop evidence-based interventions for cancer survivors.

Kevin A. Walterمشاهده پروفایل

استاد

• Neurosurgery
• Oncology
• Neuro-oncology
• +۶ مورد دیگر

Dr. Kevin A. Walter is Chief of Neurosurgery at UR Medicine's Highland Hospital and a Professor of Neurosurgery and Oncology at the University of Rochester Medical Center. He holds joint appointments in the Department of Orthopaedics (SMD) and the Cancer Center. Dr. Walter earned his MD at Johns Hopkins University School of Medicine, completed neurosurgical residency and a neuro-oncology fellowship at Johns Hopkins, and served as Director of Adult Neuro-oncology at the University of Pittsburgh before joining Rochester in 2007. Dr. Walter's research focuses on experimental therapeutics for brain and spinal tumors, with a particular emphasis on improving patient survival and quality of life through clinical trials and laboratory investigations into tumor biology. His work spans glioblastoma, radiosurgery, and complex spinal interventions. His recent publications highlight advancements in dendritic cell vaccination for glioblastoma (2023), tumor treating fields (2020), and recurrence patterns post-chemoradiation. Earlier studies (2010-2007) explored vascular gene expression, spinal cord gliomas, and radiosurgery efficacy. NREF Young Investigator Award (2003) Blue Ribbon Presentation (2001) Hunterian Resident Neurosurgical Research Award (2001) Outstanding Presentation (2000) Hunterian Medical Student Neurosurgical Research Award (1995) Alpha Omega Alpha (1995) Dr. Walter conducts clinical research evaluating experimental therapies for brain and spinal cancers, including trials on dendritic cell vaccines and tumor treating fields. He also leads a research laboratory at the University of Rochester focused on novel tumor targets and drug delivery systems like biodegradable polymers.

Pankaj Choudharyمشاهده پروفایل

استاد

• Biostatistics
• Statistical methodology
• Method comparison studies
• +۲ مورد دیگر

Pankaj Choudhary is a Professor of Statistics in the Department of Mathematical Sciences at the University of Texas at Dallas, where he also serves as the Associate Dean of Graduate Studies for the School of Natural Sciences and Mathematics since 2021. Previously, he was Associate Head of the Department of Mathematical Sciences from 2015-2021. He has been a faculty member at UTD since 2002, progressing from Assistant Professor (2002-2008) to Associate Professor (2008-2017) and finally to Professor (2017-present). His educational background includes a Ph.D. in Statistics from Ohio State University (2002), an M.S. in Statistics from the Indian Institute of Technology, Kanpur (1998), and a B.S. in Statistics from the University of Delhi (1996). Dr. Choudhary's research focuses on Biostatistics, Statistical Methodology, Method Comparison Studies, Risk Prediction, and Proteomics . His work bridges theoretical statistics with practical applications in healthcare and biomedical research. He has developed specialized statistical methods for agreement assessment in method comparison studies, which have become influential in clinical and laboratory settings where multiple measurement techniques need validation against each other. His research in risk prediction, particularly for contralateral breast cancer through the CBCRisk calculator and R package, demonstrates his commitment to translating statistical methodology into clinical decision support tools. His publication record shows a clear trajectory from foundational work in statistical methodology for method comparison studies toward increasingly sophisticated applications in biomedical research, particularly in cancer risk prediction and substance use disorder modeling. Recent work demonstrates integration of Bayesian approaches and machine learning techniques with traditional statistical methodology. Dr. Choudhary has authored two significant books in his field: "Ordered Data Analysis, Modeling and Health Research Methods" (2015) and "Measuring Agreement: Models, Methods, and Applications" (2017), the latter of which has received positive reviews in major statistical journals. He has been involved in securing research funding, including a $20,000 grant from the Actuarial Foundation (2007-2008) for work on multivariate conditional density estimation and a $100,000 grant from the American Health Assistance Foundation (2005-2007) for proteomics research related to Alzheimer's disease. Dr. Choudhary has also developed the CBCRisk calculator, an online tool for predicting personalized risk of contralateral breast cancer. As Associate Dean of Graduate Studies, he plays a significant role in shaping graduate education within the School of Natural Sciences and Mathematics. He has taught specialized short courses at major statistical conferences and summer schools, including the Joint Statistical Meetings and MESIO UPC-UB Summer School.

• Biostatistics
• Metabolic and Bariatric Surgery
• Health Disparities
• +۳ مورد دیگر

Elena Graetz is a Senior Biostatistical Analyst at Yale School of Medicine , contributing to clinical research across surgical disciplines including metabolic/bariatric surgery, breast reconstruction, and pediatric surgical outcomes. She collaborates with multidisciplinary teams on: Preoperative testing protocols Postoperative recovery patterns Health disparity analysis Surgical cost-effectiveness studies Her work synthesizes biostatistical methods with real-world clinical data to improve surgical care pathways. Recent publications focus on: Hemoglobin A1c testing trends Weight outcomes in adolescent bariatric patients Crowdfunding for surgical access Racial disparities in necrotizing infections She has received recognition for statistical consulting and teaching excellence during her academic training at University of Illinois at Chicago and Freie Universitaet Berlin.

• Breast Cancer
• Cancer Epidemiology
• Molecular Oncology
• +۳ مورد دیگر

Christopher Godina is a Postdoctoral Fellow at Lund University Cancer Center (LUCC) within the Faculty of Medicine at Lund University. His research focuses on cancer epidemiology and radiation, with a specific emphasis on breast cancer biology and molecular mechanisms. Position: Postdoctoral Fellow, Cancer Epidemiology & Radiation Institution: Lund University Cancer Center (LUCC) University: Lund University, Faculty of Medicine Email: christopher.godina@med.lu.se ORCID: 0000-0003-1501-0458 Dr. Godina's expertise spans multiple research areas including Breast Cancer (100%), Caveolin-1 (50%), Patient outcomes (42%), Prospective Cohort Studies (33%), Insulin-Like Growth Factor-Binding Proteins (33%), Therapeutic Procedures (30%), Messenger RNA expression (23%), and Contralateral cancer development (21%). His work contributes to UN Sustainable Development Goal 3: Good Health and Well-being. Analysis of Dr. Godina's publication record reveals a strong focus on molecular biomarkers in breast cancer, particularly examining Caveolin-1 expression patterns, insulin-like growth factor binding proteins (especially IGFBP7), and their clinical implications. His research spans from basic molecular mechanisms to clinical applications, with studies investigating how these biomarkers can improve risk prediction, prognosis, and treatment selection for breast cancer patients. Notably, his work published in Cell on PCSK9 germline variants driving breast cancer metastasis via LRP1 receptor demonstrates significant impact in the field. Highly cited work in Cell (2024) with 11 citation indexes and 28 Mendeley readers Multiple publications in high-impact journals including Carcinogenesis, Scientific Reports, and NPJ Precision Oncology Research focuses on translating molecular findings to clinical applications Dr. Godina actively participates in the Lund University Cancer Centre research community, having presented his work at LUCC meetings. His collaborative research involves multiple investigators at Lund University and potentially international partners, as evidenced by his multi-authored publications across various high-impact journals.

• Cancer Genetics
• Hereditary Cancer Syndromes
• Genetic Epidemiology
• +۳ مورد دیگر

Ina Giele is a researcher affiliated with the Department of Clinical Genetics at Erasmus MC. Her work focuses on cancer genetics, hereditary cancer syndromes, and genetic epidemiology. She collaborates internationally on studies investigating CHEK2, BRCA2, and PALB2 gene variants' roles in cancer risk. Key projects include nationwide cohort studies on hereditary breast and ovarian cancer, and analyses of germline variants in breast cancer survival. Her research spans genetic counseling, mismatch repair deficiencies, and exome sequencing applications. Primary affiliation: Erasmus MC, Department of Clinical Genetics Research collaborations with institutions in Europe and globally Research interests emphasize translational genetics, particularly in identifying genetic markers for cancer predisposition and improving clinical risk assessment. Recent studies address multisite cancer risks in CHEK2 mutation carriers and the impact of germline variants on contralateral breast cancer outcomes.

• Oral Cancer Diagnostics
• Vibrational Spectroscopy
• Raman Microspectroscopy
• +۵ مورد دیگر

Dr. Genecy Calado de Melo is a Lecturer in Operative and Primary Care Dentistry at the Royal College of Surgeons in Ireland (RCSI) School of Dentistry . As a registered dental surgeon with advanced training in dental medicine and a PhD in oral cancer diagnostics via vibrational spectroscopy, he bridges clinical practice with cutting-edge research. Education : PhD, Technological University Dublin (2019) MSc in Dentistry, Fernando Pessoa University (2018) Bachelor of Dental Surgery, Universidade Tiradentes (2014) Member of the Faculty of Dentistry, RCSI Research Focus: Specializing in Raman microspectroscopy for oral cancer detection , his work develops minimally invasive diagnostic protocols using saliva and brush biopsy samples . Key contributions include multiblock data analysis for improved diagnostic accuracy and standardized Raman acquisition protocols . Scientific Impact: His research has been recognized with the RCSI award at the British Society of Oral & Maxillofacial Pathology . With over 15 peer-reviewed publications, his work explores spectral differentiation of oral lesions , salivary biomarkers , and clinical applicability of biophotonics . Clinical Expertise: Prior clinical experience in primary dental care , oral medicine , and paediatric dentistry informs his translational research approach, emphasizing practical diagnostic solutions that reduce patient trauma while maintaining clinical rigor.

Anne-Lise Børresen-Daleمشاهده پروفایل

استاد

• Molecular Biology
• Breast Cancer
• Genomic Analysis
• +۳ مورد دیگر

Anne-Lise Børresen-Dale is a Professor at the Faculty of Medicine, University of Oslo, specializing in molecular tumor biology and breast cancer research. Her work focuses on genome-wide tumor analysis for personalized treatment strategies and early diagnosis. 1970: MSc in Biochemistry, Norwegian Institute of Technology 1978: PhD in Medical Biochemical Genetics, University of Oslo 1987: Professor in Genetic Technology 1992: Professor in Molecular Tumor Biology Her research spans genomic profiling , epigenetic regulation , and multi-omics integration to characterize breast cancer subtypes and predict clinical outcomes. Key contributions include developing polygenic risk scores and analyzing germline-somatic interactions . Recent publications highlight her role in deep learning pathology scoring , immune checkpoint target identification , and Mendelian randomization studies . She has supervised 36 PhD and 18 MSc students, with ongoing mentorship projects.

• Breast Cancer
• Ovarian Cancer
• BRCA1
• +۴ مورد دیگر

Annette Gerritsen is an active Researcher in the Department of Medical Oncology at Erasmus MC, Erasmus University Rotterdam, specializing in hereditary cancer syndromes with focus on Breast Cancer , Ovarian Cancer , and BRCA1/2 mutation carriers . Her work bridges oncology and cardiovascular outcomes in high-risk populations. Her research interests center on cancer risk assessment in genetic syndromes, particularly examining contralateral cancer development , salpingo-oophorectomy outcomes , and multi-site cancer risks in CHEK2 families. Current work investigates cardiovascular implications of risk-reducing surgeries using advanced imaging techniques. Recent publications (2024-2025) reveal a strong focus on cardio-oncology interfaces , with multiple studies analyzing arterial stiffness and coronary calcium scores post-salpingo-oophorectomy in BRCA carriers. Her work consistently employs multicenter prospective designs and radiological biomarker analysis . Scientific contributions: Active contributor to The Hereditary Breast and Ovarian Cancer Research Group Netherlands ORCID: 0000-0002-9724-6693 44 total research outputs including 41 articles She has supervised at least one doctoral project and collaborates extensively with national consortia including Ausems, van Leeuwen, and Maas groups. Current work emphasizes longitudinal monitoring of surgical risk-reduction outcomes and genetic risk stratification models.